Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow (2013 - 2025)
Corbus Pharmaceuticals Holdings' Net Cash Flow was $6.94 million in Q3 2025, compared with -$4.26 million a year earlier and up 506.6% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow (2013 - 2025) Analysis & Trends
On a trailing twelve-month basis, Corbus Pharmaceuticals Holdings' Net Cash Flow was $7.56 million through Sep 30, 2025, down 7.5% year-over-year; for FY2024, it was $3.47 million.
- In earlier years, Net Cash Flow was -$3.28 million in FY2023, -$8 million in FY2022, -$60.78 million in FY2021 and $54.7 million in FY2020.
- The Q3 2025 figure marks the highest quarterly Net Cash Flow since Q2 2024.
- Compared with a year earlier, Net Cash Flow was higher in two of the last four quarters, with growth averaging 262.7%.
- Per Business Quant data, CRBP's Net Cash Flow in the three quarters before Q3 2025 was $1.14 million (Q2 2025), $1.7 million (Q1 2025) and -$2.23 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | -1.27 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | -3.94 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | -722.00 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 54.43 Mn | -462.20 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 6.94 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | -4.26 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Mar 31, 2024 | 379,000.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | -9.68 Mn |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | -13.33 Mn |
| Jun 30, 2022 | -31.26 Mn |
| Mar 31, 2022 | 32.02 Mn |
| Dec 31, 2021 | -12.11 Mn |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | -30.88 Mn |
| Mar 31, 2021 | -18.82 Mn |
| Dec 31, 2020 | 3.56 Mn |
API Access
Corbus Pharmaceuticals Holdings Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();